IMO, this submission will be the next announcement, along with OSA clinical trial results, I've always said, nothing is certain in the stock market but I can't see why CE Mark won't be approved given it uses the same algorithm (different data-set but the result were as good) and clinical process as paediatric one.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Receives CE Mark for ResAppDx-EU
Ann: ResApp Receives CE Mark for ResAppDx-EU, page-574
-
- There are more pages in this discussion • 171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online